Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey
R Kones - Drug design, development and therapy, 2011 - Taylor & Francis
A recent explosion in the amount of cardiovascular risk and incipient, undetected subclinical
cardiovascular pathology has swept across the globe. Nearly 70% of adult Americans are …
cardiovascular pathology has swept across the globe. Nearly 70% of adult Americans are …
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression …
Objective To investigate the association between treatment induced change in high density
lipoprotein cholesterol and total death, coronary heart disease death, and coronary heart …
lipoprotein cholesterol and total death, coronary heart disease death, and coronary heart …
Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis
BACKGROUND: Recent data suggest that non-targeted treatment with fibrates modestly
reduces the risk of incident cardiovascular events. However the effect of fibrate treatment …
reduces the risk of incident cardiovascular events. However the effect of fibrate treatment …
Levels and changes of HDL cholesterol and apolipoprotein AI in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis
Background—It is unclear whether levels of high-density lipoprotein cholesterol (HDL-C) or
apolipoprotein AI (apoA-I) remain inversely associated with cardiovascular risk among …
apolipoprotein AI (apoA-I) remain inversely associated with cardiovascular risk among …
Cardiometabolic risk factors in young adults who were born preterm
M Sipola-Leppänen, M Vääräsmäki… - American journal of …, 2015 - academic.oup.com
Adults who were born preterm with a very low birth weight have higher blood pressure and
impaired glucose regulation later in life compared with those born at term. We investigated …
impaired glucose regulation later in life compared with those born at term. We investigated …
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial
Background HDL-cholesterol concentrations are inversely associated with occurrence of
cardiovascular events. We addressed, using the JUPITER trial cohort, whether this …
cardiovascular events. We addressed, using the JUPITER trial cohort, whether this …
HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative
Aims High-density lipoprotein (HDL) is highly heterogeneous and the link of its subclasses
to prognosis remains controversial. We aimed to rigorously examine the associations of HDL …
to prognosis remains controversial. We aimed to rigorously examine the associations of HDL …
Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children …
Background and aims The triglyceride (TG)/high-density lipoprotein-cholesterol (HDL-C)
ratio has been reported as a useful marker of atherogenic lipid abnormalities, insulin …
ratio has been reported as a useful marker of atherogenic lipid abnormalities, insulin …
Beyond high-density lipoprotein cholesterol levels: evaluating high-density lipoprotein function as influenced by novel therapeutic approaches
EM DeGoma, RL degoma, DJ Rader - Journal of the American College of …, 2008 - jacc.org
A number of therapeutic strategies targeting high-density lipoprotein (HDL) cholesterol and
reverse cholesterol transport are being developed to halt the progression of atherosclerosis …
reverse cholesterol transport are being developed to halt the progression of atherosclerosis …
[HTML][HTML] Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression
Available experimental evidence suggests a role for high-density lipoprotein cholesterol
(HDL-C) in incident chronic kidney disease (CKD) and its progression. However, clinical …
(HDL-C) in incident chronic kidney disease (CKD) and its progression. However, clinical …